Inventor

POIRIER NICOLAS

FR25 patents

⚠️ This page may combine multiple inventors who share the name “POIRIER NICOLAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

POIRIER NICOLAS

OSE IMMUNOTHERAPEUTICS

Method for treating a pathological condition involving the activation or proliferation of CD127 positive cells with an anti-CD127 antibody

Non-antagonistic antibodies directed against the alpha chain of the IL7 receptor extracellular domain and use thereof in cancer treatment

Antibodies directed against CD127

Anti-CD28 humanized antibodies

Anti-SIRPa antibodies and their therapeutic applications

Humanized anti-human-PD-1 antibody and its use in cancer treatment

Antibodies directed against CD127

Antibodies and polypeptides directed against CD127

Antibodies and polypeptides directed against CD127

Uses of anti-SIRPg antibodies

Anti-SIRPa antibodies and their therapeutic applications

Humanized anti-human-PD-1 antibody and methods of using them for cancer treatment

Anti-chemokine like receptor 1 humanized antibodies and their therapeutic applications

Modified bifunctional anti-human signal regulatory protein alpha (SIRPa) antibody and method of use thereof for treating cancer

Use of anti-human SIRPa v1 antibodies and method for producing anti-SIRPa v1 antibodies

Biomarkers for assessing the response status for treatment of Inflammatory condition or disease affecting the digestive tract such as inflammatory bowel disease in human patients

Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof

Method effector cells using anti-CD127 antibodies for applications in cell therapy

EFFIMUNE

Anti-CD28 humanized antibodies

Antibodies directed against the alpha chain of IL7 receptor—their use for the preparation of drug candidates

INST NAT SANTE RECH MED

Methods for promoting t cells response by administering an antagonist of human c-type lectin-like receptor 1 (CLEC-1)

Method of promoting a t-cell response or treating cancer by administering an antagonist to human c-type lectin-like receptor-1 (CLEC-1)

MARY CAROLINE

Anti-CD28 humanized antibodies

BESSIS ANNE-SOPHIE

Alkynyl derivatives as modulators of metabotropic glutamate receptors

AMADEUS SAS

Computing network system and method